PubMed Health treatment related to Chronic Ulcer of Skin: 62
Chronic wounds are covered with a dressing for protection. There are other treatment options in addition to regularly changing the wound dressing: Cleaning the wound Medical staff will change the wound dressing and clean the wound regularly. The wound is normally rinsed with a saline or electrolyte solution, or simply with tap water . A technique called debridement is used to remove dead cells or inflamed tissue with tweezers. Having a wound cleaned is often painful. A topical anesthetic such as a medicated ointment can be applied to the wound area to prevent pain. Larger wounds are sometimes cleaned under general anesthetic. Wound dressings After cleaning the wound , the doctor or nurse will put on a new dressing. Things like wet compresses, films or hydrogels are used as wound dressings. Their main purpose is to keep the wound moist, absorb excess fluid and prevent infection . Advanced treatments Some hospitals also use more advanced methods to help especially difficult wounds to heal: In hyperbaric oxygen therapy , patients sit in a special pressurized chamber and breathe in oxygen. In vacuum-assisted closure (VAC therapy ), fluid is continuously drawn out of the wound . Ultrasound therapy uses sound waves to treat chronic wounds . Electromagnetic therapy involves the use of magnetic cushions or mats that produce weak electric currents near the wound . Skin grafts Skin grafts may be an option for people with wounds that are too large to close on their own. The surgeon takes skin from another part of the body, often the upper leg, and transplants it to the wound . Grafts can also be made from human cell products and synthetic materials. Medication Good pain management is an important part of wound care. The pain caused by chronic wounds is often underestimated. Painkillers like acetaminophen (paracetamol) or ibuprofen tablets can help relieve mild to moderate pain. Your doctor can prescribe stronger painkillers if these do not provide enough relief. Wound dressings that contain ibuprofen are also available. Antibiotics can be used to treat wounds infected with bacteria .
Drugs for Chronic Ulcer of Skin (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 144)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Polihexanide |
Approved, Investigational |
Phase 4 |
|
28757-47-3 |
|
Synonyms:
Polyhexamethylene biguanide
|
|
|
2 |
|
Zinc |
Approved, Investigational |
Phase 4 |
|
7440-66-6 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
3 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(diethylamino)-2',6'-Acetoxylidide
2-(Diethylamino)-2',6'-acetoxylidide
2-(diethylamino)-N-(2,6-Dimethylphenyl)acetamide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-diethylamino-2,6-Dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-Dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
Leostesin
|
Lida-Mantle
Lidocaina
Lidocaína
Lidocaina [INN-Spanish]
lidocaine
Lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
|
|
4 |
|
Betaine |
Approved, Nutraceutical |
Phase 4 |
|
107-43-7 |
247 |
Synonyms:
(Carboxymethyl)trimethylammonium hydroxide inner salt
(trimethylammonio)Acetate
(Trimethylammoniumyl)acetate
(Trimethylammoniumyl)acetic acid
1-Carboxy-N,N,N-trimethyl-methanaminium
1-Carboxy-N,N,N-trimethyl-methanaminium hydroxide
1-Carboxy-N,N,N-trimethylmethanaminium inner salt
2-(Trimethylammonio)Acetate
2-N,N,N-trimethylammonio acetate
2-N,N,N-trimethylammonio Acetate
2-N,N,N-trimethylammonio Acetic acid
2-trimethylammonioacetate
abromine
Abromine
Acidin pepsin
Acidin-pepsin
AcidinPepsin
acidol
Acidol
a-Earleine
alpha-Earleine
Aminocoat
Beaufour brand OF betaine citrate
Bet
Betafin
Betafin BCR
Betafin BP
betaína anhidra
Betaine
Betaine hydrochloride
Betaine orphan brand
Betaine, anhydrous
Betaine, glycine
Boizot brand OF betaine aspartate
Byk brand OF betaine phosphate
C.B.B.
Citrate de bétaïne beaufour
Citrate de bétaïne upsa
|
Cystadane
Ektasolve ee
FinnStim
Fournier brand OF betaine ascorbate and hydrate
Glycine betaine
Glycinebetaine
Glycocoll betaine
Glycylbetaine
Greenstim
Hepastyl
Hydrochloride, betaine
Logeais brand OF betaine cyclobutyrate
Loramine amb 13
Loramine amb-13
Lycine
N,N,N-trimethylammonioacetate
N,N,N-Trimethylammonioacetate
N,N,N-Trimethylammonioacetic acid
N,N,N-Trimethylglycine
Novobetaine
Orphan brand OF betaine
Oxyneurine
Rubrine C
scorbo Bétaïne
scorbo-Bétaïne
Scorbobétaïne
Stea16
Stea-16
TMG
Trimethylaminoacetate
Trimethylaminoacetic acid
Trimethylammonioacetate
Trimethylammonioacetic acid
Trimethylbetaine glycine
Trimethylglycine
trimethylglycocoll
Trimethylglycocoll
UPSA brand OF betaine citrate
|
|
5 |
|
Octenidine |
Investigational |
Phase 4 |
|
71251-02-0 |
|
6 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
7 |
|
Pulmonary Surfactants |
|
Phase 4 |
|
|
|
8 |
|
Laxatives |
|
Phase 4 |
|
|
|
9 |
|
Cathartics |
|
Phase 4 |
|
|
|
10 |
|
Carboxymethylcellulose Sodium |
|
Phase 4 |
|
|
|
11 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
12 |
|
Benzalkonium Compounds |
|
Phase 4 |
|
|
|
13 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
14 |
|
insulin |
|
Phase 4 |
|
|
|
15 |
|
Insulin, Globin Zinc |
|
Phase 4 |
|
|
|
16 |
|
Anesthetics |
|
Phase 4 |
|
|
|
17 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
18 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
19 |
|
Silicon |
Approved, Investigational |
Phase 2, Phase 3 |
|
7440-21-3 |
4082203 |
Synonyms:
|
Silicate
Silicic acid
silicio
|
|
20 |
|
Pantoprazole |
Approved |
Phase 3 |
|
102625-70-7 |
4679 |
Synonyms:
102625-70-7
5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole
5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole
AC1L1IPJ
AC-679
Astropan
BIDD:GT0003
BRD-A22380646-001-01-5
BSPBio_002320
BY 1023
BY-1023
C11806
C16H15F2N3O4S
CHEBI:519598
CHEBI:7915
CHEMBL1502
CID4679
D05353
DB00213
HMS1922H20
HMS2090H03
HMS2093F14
HSDB 7292
I06-0068
LS-32883
MolPort-003-666-752
MolPort-005-933-577
NCGC00095188-01
NCGC00095188-02
NCGC00095188-03
Pantoloc
|
Pantopan
Pantoprazol
Pantoprazol [INN-Spanish]
pantoprazole
Pantoprazole
Pantoprazole (USAN/INN)
Pantoprazole [USAN:BAN:INN]
Pantoprazole Na
Pantoprazole sodium
Pantoprazole Sodium
Pantoprazole sodium hydrate
Pantoprazolum
Pantoprazolum [INN-Latin]
Pantoprozole
Pantor
Pantozol
Protium
Protonix
Protonix i.v.
Protonix I.V.
Protonix IV
SBB070993
SK And F 96022
SK And F-96022
SK&F 96022
SK&F-96022
SK-96022
SKF-96022
Somac
SPECTRUM1505818
TL8000127
UNII-D8TST4O562
|
|
21 |
|
Metronidazole |
Approved |
Phase 3 |
|
443-48-1 |
4173 |
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitro-1-imidazoleethanol
2-methyl-5-nitroimidazole-1-ethanol
2-Methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
Acromona
AKOS000269646
Anagiardil
APMN
Apo-Metronidazole
Arilin
ARONIS24285
Atrivyl
BAS 02983617
BAY-5360
Bayer 5360
BCBcMAP01_000184
Bexon
BIDD:GT0107
Bio-0694
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
CAS-443-48-1
Caswell No. 579AA
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
Clont
CONT
CPD000058175
D00409
Danizol
DB00916
Deflamon
Deflamon-wirkstoff
DivK1c_000007
Efloran
EINECS 207-136-1
Elyzol
Entizol
EPA Pesticide Chemical Code 120401
Eumin
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
giniflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
Hydrochloride, metronidazole
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
Metric
Metric 21
Metro Cream
Metro Gel
METRO I.V
|
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
Metrodzhil
MetroGel
MetroGel-Vaginal
Metrogel-vaginal (TN)
Metrogyl
Metrolag
MetroLotion
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
metronidazole
Metronidazole
Métronidazole
Metronidazole (JP15/USP/INN)
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole benzoate
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole in Plastic Container
Metronidazole monohydrochloride
Metronidazole Monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazole Phosphoester
METRONIDAZOLE USP
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MLS000028590
MLS000758286
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
neo-Tric
NIDA
Nidagel
NINDS_000007
Noritate
Noritate (TN)
Novonidazol
NSC 50364
NSC 69587
NSC50364
NSC-50364
NSC69587
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
Prestwick_334
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Protostat
Rathimed
Rosased
RP 8823
RP-8823
S1907_Selleck
SAM001247010
Sanatrichom
Satric
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
Spectrum_001035
SPECTRUM1500412
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
STK177359
Takimetol
Trichazol
Trichex
Tricho cordes
Trichocide
Tricho-gynaedron
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
Wagitran
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Zadstat
ZERO/004064
Zidoval
ZINC00113442
|
|
22 |
|
Becaplermin |
Approved, Investigational |
Phase 3 |
|
165101-51-9 |
|
Synonyms:
165101-51-9
Becaplermin
Becaplermin (USAN/INN)
D03065
PDGF-2
PDGFB
PDGF-BB
Platelet-derived growth factor BB, recombinant
|
Platelet-derived growth factor beta polypeptide
Recombinant platelet-derived growth factor BB
Regranex
Regranex (TN)
rhPDGF-BB
rPDGF-BB
SH-POLYPEPTIDE-59
|
|
23 |
|
Morphine |
Approved, Investigational |
Phase 3 |
|
57-27-2 |
5288826 |
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(−)-morphine
(-)-Morphine
(-)Morphine sulfate
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-didehydro-4,5-Epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-didehydro-4,5-Epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
47106-99-0
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
8053-16-5
85201-37-2
Anhydrous morphine
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
Chloride, morphine
CID5288826
Contin, MS
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
Depodur
DepoDur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
|
HSDB 2134
Infumorph
Kadian
l-Morphine
LS-91748
M.O.S
Meconium
M-Eslon
MOI
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
morphine
Morphine
Morphine [BAN]
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine Sulfate
MORPHINE SULFATE
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
MS Contin
Ms Emma
MS/L
MS/S
MSIR
nchembio.317-comp1
nchembio.64-comp1
Nepenthe
NSC11441
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
Rescudose
RMS
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
Sulfate, morphine
UNII-76I7G6D29C
Unkie
|
|
24 |
|
Thrombin |
Approved, Investigational |
Phase 3 |
|
|
|
Synonyms:
coagulation factor II
Thrombin bovine
|
Thrombin, Topical (Bovine)
|
|
25 |
|
Trace Elements |
|
Phase 2, Phase 3 |
|
|
|
26 |
|
Nutrients |
|
Phase 2, Phase 3 |
|
|
|
27 |
|
Micronutrients |
|
Phase 2, Phase 3 |
|
|
|
28 |
|
Proton Pump Inhibitors |
|
Phase 3 |
|
|
|
29 |
|
Antacids |
|
Phase 3 |
|
|
|
30 |
|
Anti-Ulcer Agents |
|
Phase 3 |
|
|
|
31 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
32 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
33 |
|
Disinfectants |
|
Phase 3 |
|
|
|
34 |
|
Mitogens |
|
Phase 3 |
|
|
|
35 |
|
protease inhibitors |
|
Phase 3 |
|
|
|
Synonyms:
|
36 |
|
HIV Protease Inhibitors |
|
Phase 3 |
|
|
|
37 |
|
Angiogenesis Inducing Agents |
|
Phase 3 |
|
|
|
38 |
|
Narcotics |
|
Phase 3 |
|
|
|
39 |
|
Analgesics, Opioid |
|
Phase 3 |
|
|
|
40 |
|
Analgesics |
|
Phase 3 |
|
|
|
41 |
|
Hemostatics |
|
Phase 3 |
|
|
|
42 |
|
Coagulants |
|
Phase 3 |
|
|
|
43 |
|
leucovorin |
Approved |
Phase 2 |
|
58-05-9 |
6006 143 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-formyltetrahydrofolate
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
Acid, folinic
Acide folinique
Acido folinico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
44 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 2 |
|
738-70-5 |
5578 |
Synonyms:
2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
2,4-diamino-5-(3,4,5-Trimethoxybenzyl)pyrimidine
46984_FLUKA
46984_RIEDEL
5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
738-70-5
92131_FLUKA
92131_SIGMA
AB00052118
AB1004879
Abacin
Abaprim
AC-13572
AC1L1KNQ
AC1Q48DF
AI3-52594
AKOS001650069
Alcorim-F
Alprim
Anitrim
Antrima
Antrimox
Apo-Sulfatrim
ARONIS24118
AZT + TMP/SMX (mixture) combination
Bacdan
Bacidal
Bacide
Bacin
Bacta
Bacterial
Bacterial [Antibiotic]
Bacticel
Bactin
Bactoprim
Bactramin
Bactrim
Bactrim DS
Bactrim Pediatric
Baktar
BB_SC-2116
Bencole
Bethaprim
BIDD:GT0190
Biosulten
BPBio1_000215
BRD-K07208025-001-06-5
Briscotrim
BRN 0625127
BSPBio_000195
BSPBio_002245
BW 5672
BW 56-72
BW-56-72
C01965
CAS-738-70-5
CCRIS 2410
CHEBI:45924
CHEMBL22
Chemotrim
Chemotrin
CID5578
Cidal
Colizole
Colizole DS
Comox
component of Bactrim
component of Septra
Conprim
Cotrim
Cotrim D.S.
Cotrimel
CO-Trimoxazole
Co-Trimoxizole
CPD000035999
CPD0-1581
D00145
D014295
DB00440
Deprim
DivK1c_000589
Drylin
Duocide
EINECS 212-006-2
Esbesul
Espectrin
EU-0101271
Euctrim
Eusaprim
Exbesul
Fectrim
Fermagex
Fortrim
Futin
Gantaprim
Gantrim
HMS1568J17
HMS1921I03
HMS2090D14
HMS2092A10
HMS501N11
HSDB 6781
I06-0086
IDI1_000589
Idotrim
Ikaprim
Imexim
Instalac
Ipral
KBio1_000589
KBio2_000647
KBio2_003215
KBio2_005783
KBio3_001465
KBioGR_000863
KBioSS_000647
Kepinol
Kombinax
KSC-4-158
KUC103659N
Lagatrim
Lagatrim Forte
Laratrim
Lastrim
Lidaprim
Linaris
Lopac0_001271
Lopac-T-7883
LS-1627
Methoprim
Metoprim
Microtrim
MLS000079023
MLS001201740
MLS002303068
MolPort-001-826-685
Monoprim
Monotrim
Monotrimin
NCGC00016055-01
NCGC00016055-02
NCGC00016055-06
NCGC00016055-12
NCGC00024707-01
NCGC00024707-03
NCGC00024707-04
NCGC00024707-05
NCGC00024707-06
NCGC00024707-07
|
NCGC00024707-08
nchembio.108-comp1
nchembio.215-comp11
nchembio.221-comp23
NIH 204
NIH 204 (VAN)
NINDS_000589
Nopil
Novotrimel
NSC 106568
NSC106568
NSC-106568
Omstat
Oprea1_495058
Oraprim
Pancidim
Polytrim
Prestwick_485
Prestwick0_000208
Prestwick1_000208
Prestwick2_000208
Prestwick3_000208
Priloprim
Primosept
Primsol
Proloprim
Proloprim (TN)
Protrin
Purbal
Resprim
Resprim Forte
Roubac
Roubal
Salvatrim
SAM002264649
Septra
Septra DS
Septra Grape
Septrin
Septrin DS
Septrin Forte
Septrin S
Setprin
Sigaprim
Sinotrim
SMP2_000262
SMR000035999
Smz-Tmp
SPBio_000874
SPBio_002116
Spectrum_000167
SPECTRUM1500595
Spectrum2_000937
Spectrum3_000643
Spectrum4_000372
Spectrum5_001559
STK177322
Stopan
Streptoplus
Sugaprim
Sulfamar
Sulfamethoprim
Sulfamethoprim-DS
Sulfamethoxazole & Trimethoprim
Sulfatrim
Sulfatrim Pediatric
Sulfatrim-DS
Sulfatrim-SS
Sulfotrim
Sulfoxaprim
Sulmeprim
Sulmeprim Pediatric
Sulprim
Sulthrim
Sultrex
Sumetrolim
Supracombin
Suprim
Syraprim
T 7883
T2286
T7883_SIGMA
TCMDC-125538
Teleprim
Thiocuran
Tiempe
TL8005108
TMP/SMX (MIXTURE))
Tmp-Ratiopharm
Tocris-0650
Toprim
Trigonyl
Trimanyl
Trimesulf
Trimeth/Sulfa
Trimethioprim
Trimethopim(TMP)
trimethoprim
Trimethoprim
Trimethoprim & VRC3375
Trimethoprim (JAN/USP/INN)
Trimethoprim [USAN:BAN:INN:JAN]
Trimethoprime
Triméthoprime
Trimethoprime [INN-French]
Trimethoprimum
Trimethoprimum [INN-Latin]
Trimethopriom
Trimetoprim
Trimetoprim [DCIT]
Trimetoprim [Polish]
Trimetoprima
Trimetoprima [INN-Spanish]
Trimexazole
Trimexol
Trimez-IFSA
Trimezol
Trimogal
Trimono
Trimopan
Trimpex
Trimpex (TN)
Trimpex 200
Triprim
Trisul
Trisulcom
Trisulfam
Trisural
UNII-AN164J8Y0X
Unitrim
UPCMLD-DP132
UPCMLD-DP132:001
U-Prin
Uretrim
Urobactrim
Uro-D S
Uroplus
Uroplus DS
Uroplus SS
Uro-Septra
Utetrin
Velaten
Wellcoprim
Wellcoprin
WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1
WR 5949
Xeroprim
Zamboprim
ZINC06627681
|
|
45 |
|
Methyl salicylate |
Approved, Vet_approved |
Phase 2 |
|
119-36-8 |
4133 |
Synonyms:
2-(Methoxycarbonyl)phenol
2-Carbomethoxyphenol
2-Hydroxybenzoate methyl ester
2-Hydroxybenzoic acid methyl ester
Benzoic acid, 2-hydroxy-, methyl ester
Betula oil
FEMA 2745
Gaultheria oil
Hewedolor
Linsal
Methyl 2-hydroxybenzoate
Methyl 2-hydroxybenzoic acid
Methyl ester 2-hydroxy-benzoic acid
Methyl o-hydroxybenzoate
Methyl O-hydroxybenzoate
|
Methyl O-hydroxybenzoic acid
Methyl salicylate
Methyl salicylate sodium salt
Methyl salicylate, 8ci
Methylsalicylate
Metsal liniment
Natural wintergreen oil
O-Hydroxybenzoic acid, methyl ester
Oil of wintergreen
Oil OF wintergreen
Rheumabal
Spicewood oil
Spicewood Oil
Sweet birch oil
Teaberry oil
|
|
46 |
|
Sodium citrate |
Approved, Investigational |
Phase 1, Phase 2 |
|
68-04-2 |
|
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
|
Sodium citrate, anhydrous
Sodium citrate,anhydrous
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
47 |
|
Papain |
Approved |
Phase 1, Phase 2 |
|
9001-73-4 |
|
Synonyms:
|
48 |
|
Hydroxychloroquine |
Approved |
Phase 1, Phase 2 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
747-36-4 (sulfate (1:1) salt)
7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[4-(N-Ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[4-(N-Ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
AC1L1GEW
Axemal
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
Dolquine
EINECS 204-249-8
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
|
Hidroxicloroquina
Hidroxicloroquina [inn-spanish]
Hidroxicloroquina [INN-Spanish]
HMS502P04
Hydroxychlorochin
Hydroxychloroguine
hydroxychloroquine
Hydroxychloroquine
Hydroxychloroquine (INN)
Hydroxychloroquine [INN:BAN]
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [dcit]
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Plaquenil
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
Spectrum2_001238
Spectrum5_001697
ST072188
UNII-4QWG6N8QKH
WIN 1258
|
|
49 |
|
Petrolatum |
Approved, Investigational |
Phase 1, Phase 2 |
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
50 |
|
Carbon monoxide |
Approved, Investigational |
Phase 2 |
|
630-08-0 |
281 |
Synonyms:
[co]
C#O
Carbon monoxide
carbon(II) oxide
|
Carboneum oxygenisatum
CO
Monoxide, carbon
|
|
Interventional clinical trials:
(show top 50)
(show all 293)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System |
Unknown status |
NCT01113658 |
Phase 4 |
|
2 |
The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound |
Unknown status |
NCT00813631 |
Phase 4 |
|
3 |
Wound Fluid Protease Levels During Use of Novel Wound Dressing |
Completed |
NCT01567150 |
Phase 4 |
|
4 |
A Prospective, Open Labelled, Multicentre Evaluation of the Use of EZCareâ—Š in the Management of Acute and Chronic Wounds |
Completed |
NCT00994162 |
Phase 4 |
|
5 |
Evaluation of Provase in the Post Burn Rehabilitation Population for Itch Control and Moisturization Properties |
Completed |
NCT00782054 |
Phase 4 |
|
6 |
Effect of Pulsed Electromagnetic Fields on Postoperative Recovery After TRAM Flap Breast Reconstruction |
Completed |
NCT01262599 |
Phase 4 |
|
7 |
A Prospective, Double-blind, Randomized, Controlled Clinical Trial Comparing Standard Wound Care With Adjunctive Hyperbaric Oxygen Therapy (HBOT) to Standard Wound Care Only for the Treatment of Chronic, Non-healing Ulcers of the Lower Limb in Patients With Diabetes Mellitus. |
Completed |
NCT00621608 |
Phase 4 |
|
8 |
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications |
Completed |
NCT01229358 |
Phase 4 |
|
9 |
A Prospective Randomized Trial Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation |
Completed |
NCT01939145 |
Phase 4 |
Normal saline |
10 |
Effectiveness of a Hydrophobic Dressing for Microorganisms' Colonization and Infection Control of Vascular Ulcers: An Open, Controlled, Randomized Study, With Blinded Endpoint (PROBE Trial): CUCO-UV Study |
Recruiting |
NCT03667937 |
Phase 4 |
|
11 |
GrafixPL PRIME Evaluation Case Study |
Active, not recruiting |
NCT03742440 |
Phase 4 |
|
12 |
Investigating the Effect of an Anti-Biofilm Solution to Reduce Bacterial Burden and Accelerate Healing in Chronic Wounds. |
Active, not recruiting |
NCT03686904 |
Phase 4 |
Benzalkonium Gel;benzalkonium irrigation |
13 |
Effect of Insulin on Wound Healing- A Randomized Controlled Trial |
Not yet recruiting |
NCT04390815 |
Phase 4 |
Insulin |
14 |
The F.L.I.G.H.T. (Fluorescence Image-Guided Healing Trial) for Diabetic Foot Ulcers: A Phase IV Trial |
Not yet recruiting |
NCT04163055 |
Phase 4 |
|
15 |
Estimation of MMP-8 Levels in GCF and Serum and Its Correlation With Wound Healing and Clinical Outcomes After Coronally Advanced Flap and Subepithelial Connective Tissue Graft for Root Coverage in Recession Defects: A CLINICO-BIOCHEMICAL STUDY |
Suspended |
NCT02863744 |
Phase 4 |
|
16 |
Randomized, Double-blind, Single-center, Placebo-controlled Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds |
Terminated |
NCT01434914 |
Phase 4 |
octenisept®;Placebo |
17 |
Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs |
Terminated |
NCT01608776 |
Phase 4 |
|
18 |
A Prospective Single Center Within Subject Controlled Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa |
Terminated |
NCT01619670 |
Phase 4 |
|
19 |
A Randomized Comparison of AmnioClearâ„¢ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds |
Withdrawn |
NCT02120755 |
Phase 4 |
|
20 |
Stem Cells In Wound Healing With Collagen Matrix as a Carrier |
Withdrawn |
NCT02314416 |
Phase 4 |
|
21 |
A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in Venous Leg Ulcers |
Withdrawn |
NCT02940587 |
Phase 4 |
|
22 |
A Prospective, Randomized, Controlled Study of MIST Therapy's Effectiveness in Wound Bed Preparation and the Role of Bacterial Biofilm in Subjects Presenting With Chronic, Non-healing Wounds |
Withdrawn |
NCT01125735 |
Phase 4 |
|
23 |
Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy |
Unknown status |
NCT00678847 |
Phase 2, Phase 3 |
|
24 |
Evaluation of the Therapeutic Effect of Platelet Rich Plasma in Melasma |
Unknown status |
NCT03308370 |
Phase 3 |
|
25 |
A Prospective, Open, Non-controlled Proof-of-concept Investigation to Evaluate the Function of a New Silicon Cover Film and an On-top Suction Device to be Used in a NPWT System in the Treatment of Acute and Chronic Wounds |
Completed |
NCT01286857 |
Phase 2, Phase 3 |
|
26 |
Evaluation of a Medical Food for Chronic Wounds |
Completed |
NCT00711217 |
Phase 3 |
|
27 |
A Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Soluble Beta-1,3/1,6-glucan (SBG) in Chronic Foot Ulcers in Patients With Diabetes |
Completed |
NCT00804414 |
Phase 3 |
SBG;Placebo Comparator |
28 |
An Open Randomised Comparative Study to Evaluate the Performance of AQUACEL® Extraâ„¢ in Venous Leg Ulcers |
Completed |
NCT01591434 |
Phase 3 |
|
29 |
A Comparative Efficacy Study: Treatments of Non-Healing Diabetic Foot Ulcers |
Completed |
NCT01450943 |
Phase 3 |
|
30 |
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial |
Completed |
NCT00909870 |
Phase 3 |
|
31 |
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing |
Completed |
NCT01214811 |
Phase 3 |
|
32 |
Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints |
Completed |
NCT00261300 |
Phase 3 |
Pantoprazole |
33 |
Randomized Controlled Study for Evaluation of the Impact of Red Wine, White Wine and Beer Intake on Contrast-Medium Induced Acute Kidney Injury |
Completed |
NCT01562925 |
Phase 3 |
|
34 |
Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide: Randomized Clinical Trial |
Completed |
NCT02394821 |
Phase 3 |
Polihexanide 2%;Metronidazole 0.8% |
35 |
VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
Recruiting |
NCT04227106 |
Phase 3 |
|
36 |
Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing |
Not yet recruiting |
NCT02845466 |
Phase 3 |
|
37 |
Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics |
Not yet recruiting |
NCT04172363 |
Phase 3 |
Octenisept and Serasept |
38 |
Phase III Study Evaluating the Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds |
Terminated |
NCT02028923 |
Phase 3 |
Morphine gel |
39 |
Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum In The Treatment Of Recalcitrant Venous Stasis Ulcers |
Terminated |
NCT02802995 |
Phase 3 |
PRP/thrombin mixture |
40 |
A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss |
Unknown status |
NCT02544204 |
Phase 2 |
|
41 |
Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy |
Unknown status |
NCT00043797 |
Phase 2 |
Lidorestat (IDD 676) |
42 |
Effect of SACCHACHITIN on Healing of Chronic Wound ---A Clinical Trial |
Unknown status |
NCT00117364 |
Phase 2 |
SACCHACHITIN patch |
43 |
Study Assessing Safety and Efficacy of B-cure Laser Treating Diabetic Chronic Wounds |
Unknown status |
NCT01493895 |
Phase 1, Phase 2 |
|
44 |
A Double-blind, Placebo-controlled Clinical Trial to Evaluate the Effects of Catechol-O-Methyltransferase (COMT) Inhibition on Cognition and Neuropsychiatric Symptoms in Patients With a History of Acquired Brain Injuries |
Unknown status |
NCT03273062 |
Phase 2 |
Tolcapone 200 MG |
45 |
A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers. |
Completed |
NCT01396837 |
Phase 2 |
|
46 |
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds |
Completed |
NCT02092870 |
Phase 2 |
Adipose derived stem cells |
47 |
Open Label Study (Phase 2) to Evaluate the Safety, Tolerance and Efficacy of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs |
Completed |
NCT01111695 |
Phase 2 |
|
48 |
Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing |
Completed |
NCT00618787 |
Phase 2 |
|
49 |
Treatment of Pressure Ulcers With Autologous Bone Marrow Stem Cells in Spinal Cord Injury Patients.Phase I/II Study. |
Completed |
NCT01572376 |
Phase 1, Phase 2 |
|
50 |
Chronic Wounds Reference Nurse and Telematic Interconsultation Program for Pressure Ulcers in Primary Care: Evaluation of Effectiveness and Cost Reduction |
Completed |
NCT01877681 |
Phase 2 |
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Chronic Ulcer of Skin:
Embryonic/Adult Cultured Cells Related to Chronic Ulcer of Skin:
|